Amphista Eclipsys News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ -- Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced a Series B extension...

Dementia Discovery Fund invests in Amphista Therapeutics as it targets neurodegenerative diseases - read this article along with other careers information, tips and advice on BioSpace